Literature DB >> 30868564

Microbiome programming of brain development: implications for neurodevelopmental disorders.

Hans Forssberg1.   

Abstract

During the last decade, research on germ-free mice has discovered that the gut microbiome (i.e. the normal bacteria colonizing the gastrointestinal tract) can programme brain function and behaviour during early development. At the same time a growing number of clinical studies have shown altered gut microflora in children with autism spectrum disorder (ASD), in combination with altered bacterial metabolites and inflammatory cytokines being part of the gut-brain axis. This review covers the concept of the microbiome; how it is established during childhood; how it is affected by malnutrition; how it can programme the development of the brain through epigenetic mechanisms; which pathways are used from the gut to the brain; and assesses findings that suggest the gut microbiome may be involved in ASD and other neurodevelopmental disorders. This is a new research field with a number of exciting, but so far fragmented, findings indicating the important role of the normal microbiome in shaping the brain. Research also suggests that disruptions of the microbiome may be involved in the aetiology of neurodevelopmental disorders. WHAT THIS PAPER ADDS: The gut microbiome shapes the brain via the gut-brain axis. The microbiome may play a role in neurodevelopmental disorders.
© 2019 Mac Keith Press.

Entities:  

Mesh:

Year:  2019        PMID: 30868564     DOI: 10.1111/dmcn.14208

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  7 in total

1.  The Efficacy of Fecal Transplantation and Bifidobacterium Supplementation in Ameliorating Propionic Acid-Induced Behavioral and Biochemical Autistic Features in Juvenile Male Rats.

Authors:  Sameera Abuaish; Norah M Al-Otaibi; Kawther Aabed; Turki S Abujamel; Saleha Ahmad Alzahrani; Sohailah Masoud Alotaibi; Ramesa Shafi Bhat; Shaista Arzoo; Norah Algahtani; Nadine Ms Moubayed; Afaf El-Ansary
Journal:  J Mol Neurosci       Date:  2022-01-30       Impact factor: 3.444

2.  Zinc is a key regulator of gastrointestinal development, microbiota composition and inflammation with relevance for autism spectrum disorders.

Authors:  Ann Katrin Sauer; Sigita Malijauskaite; Paula Meleady; Tobias M Boeckers; Kieran McGourty; Andreas M Grabrucker
Journal:  Cell Mol Life Sci       Date:  2021-12-22       Impact factor: 9.261

3.  Evidence for long-lasting alterations in the fecal microbiota following prenatal alcohol exposure.

Authors:  Tamara S Bodnar; Christopher Lee; Athena Wong; Ilan Rubin; Laura Wegener Parfrey; Joanne Weinberg
Journal:  Alcohol Clin Exp Res       Date:  2022-02-17       Impact factor: 3.928

Review 4.  A Revolutionizing Approach to Autism Spectrum Disorder Using the Microbiome.

Authors:  Dinyadarshini Johnson; Vengadesh Letchumanan; Sivakumar Thurairajasingam; Learn-Han Lee
Journal:  Nutrients       Date:  2020-07-03       Impact factor: 5.717

5.  Neonatal Consumption of Oligosaccharides Greatly Increases L-Cell Density without Significant Consequence for Adult Eating Behavior.

Authors:  Gwenola Le Dréan; Anne-Lise Pocheron; Hélène Billard; Isabelle Grit; Anthony Pagniez; Patricia Parnet; Eric Chappuis; Malvyne Rolli-Derkinderen; Catherine Michel
Journal:  Nutrients       Date:  2019-08-21       Impact factor: 5.717

6.  The role of probiotics in children with autism spectrum disorders: A study protocol for a randomised controlled trial.

Authors:  Lingling Zhang; Yiran Xu; Hongwei Li; Bingbing Li; Guiqin Duan; Changlian Zhu
Journal:  PLoS One       Date:  2022-02-24       Impact factor: 3.240

Review 7.  Role of Gut Microbiome in Autism Spectrum Disorder and Its Therapeutic Regulation.

Authors:  Masuma Afrin Taniya; Hea-Jong Chung; Abdullah Al Mamun; Safaet Alam; Md Abdul Aziz; Nazim Uddin Emon; Md Minarul Islam; Seong-T Shool Hong; Bristy Rani Podder; Anjuman Ara Mimi; Suzia Aktar Suchi; Jian Xiao
Journal:  Front Cell Infect Microbiol       Date:  2022-07-22       Impact factor: 6.073

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.